Viewing Study NCT00005033


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-26 @ 1:31 AM
Study NCT ID: NCT00005033
Status: COMPLETED
Last Update Posted: 2013-06-21
First Post: 2000-04-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trastuzumab in Treating Patients With Recurrent Osteosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module